Fierce Biotech August 1, 2024
Veteran venture capital firm venBio has raised another half a billion dollars to invest in biotechs working on diseases with unmet needs. The $528 million raised for “Fund V” lines up nicely with the $550 million brought in for its fourth fund in 2021 and once again surpasses the comparatively paltry $394 million raised in 2020.
Fundraising for the VC’s fifth life sciences fund began mid-April, with investors coming from diverse walks of life, including sovereign wealth funds, corporate pensions, financial institutions, university endowments, medical institutions, foundations, family offices and funds-of-funds.
Like in previous funds, the San Francisco-based firm is interested in investing across...
Today's Sponsors
Today's Sponsor